Novo Nordisk CEO sees 15 million-patient opportunity in Medicare coverage for obesity drugs

5 days ago 10
ARTICLE AD BOX

Novo Nordisk CEO Mike Doustdar.

CNBC

Novo Nordisk

Read Entire Article